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ADVANCING KNOWLEDGE, PROTECTING INFORMATION:  PRECISION MEDICINE AND POPULATION 
HEALTH RESEARCH IN HEALTH SYSTEMS 
 
Raj C. Shah, Alissa Bugh, Mary Jane Welch, Andrew Reeder* 
 
I. INTRODUCTION 
 
In order to achieve the highest value for the resources spent on the provision of health care, the 
delivery of health care in the United States must change.  The health care enterprise in the United States 
strives to reclaim global leadership in achieving better health care outcomes for a diverse and inclusive 
population, better care experiences for individuals, and better use of resources for health and care.  Achieving 
these goals requires the transformation of the health care system into a learning health system where practice 
influences research and research influences practice.  Linking research with practice requires understanding 
the health of large groups of individuals as well as understanding the health of single individuals – an idea that 
is often described simply as “precision medicine.”  Forces accelerating precision medicine include patient 
partnerships, mobile technologies, genomics, data science, and electronic health records. Forces resisting 
change include various laws created at times when technological advances did not exist.  In this article, we 
explore the tensions between technologies advancing large scale health data sharing and health data privacy 
and security.  We highlight potential evolutionary changes to help reconcile the tensions along with more 
disruptive innovations.   
       
II. BACKGROUND 
Why Health Care Must Change 
 
Health care in the United States needs to undergo significant changes.  In the last almost 80 years, the 
life expectancy at birth for women has increased from 65.2 years in 1940 to 80.1 years in 2003.1 For men, the 
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life expectancy at birth has moved from 60.8 years in 1940 to 74.8 years in 2003.2 The total number of persons 
over age 65 has increased from 9 million in 1940 to 47.8 million in 2015 and is projected to increase to 98.2 
million by 2060.3 While life expectancy has increased, persistent gaps in health equity continue to be present 
even though reduced.  For instance, the difference in life expectancy at birth between black men and white 
men was slightly above 7 years in 1970 but was still 6.3 years in 2003.4 The difference in life expectancy at 
birth between women and men was 4.4 years in 1940 but had increased to 5.3 years by 2003.5  In a recent 
report by the Commonwealth Fund comparing health care systems on dimensions of quality care, access, 
efficiency, equity, and healthy lives, the United States far exceeded the remaining 10 developed nations with a 
health expenditure per capita (in 2011 US dollars) of over $8,500 while the second closest nation (the 
Netherlands) spent a little over $5,600.6  For that expenditure of resources, the United States received an 
overall health care ranking of 11 while the United Kingdom received a ranking of 1.7  The highest ranking the 
United States received was 3 out of 11 for effective care.8  These issues have led the United States over the 
last 5 years to embark on achieving the “Triple Aim,” which includes: (1) better outcomes for the local 
population, (2) better care and experience for individuals, and (3) better use of resources for health and care.9   
 
How Can Health Care Change 
 
In order to achieve the Triple Aim, health care must be transformed into a learning health system.10  In 
a learning health care system, practice influences research and research influences practice.  A continuous 
cycle is needed for learning health systems to engage with their environments, adapt and find solutions.  
Internal and external scans are required to identify problems.  With the identification of problems that matter, 
design of a solution plan is needed that can be implemented in pilot settings. Collecting data and analyzing 
data can evaluate what works or does not work.  The evidence generated leads to solution optimization in an 
iterative process.  Finally, solutions are shared broadly to improve care for everyone through informing policy.  
The idea of a learning health system has been incorporated into a cyclical model of the United States Food 
and Drug Administration (“FDA”) to optimize the cycle of driving discovery science to early translational steps 
followed by clinical trials, clinical practice guidelines, performance measures, and outcomes.11   
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Why Population Health Research  
 
Most research to understand health and health care delivery focuses on information collected from sub-
groups.  Results from limited samples then are extrapolated to the entire population using statistical 
techniques.  As a result, there is a higher chance for research to have external validity as the sample selected 
may never fully represent the entire population.  Cost of data collection is a large contribution to needing 
sampling techniques in research.  The closest data collection mechanism to engage every potential person in 
the United States is the US Census.  Written into the US Constitution and required to be conducted every 10 
years, the attempt to count every single person in the United States had a cost of approximately $12 billion in 
2010.12  However, the cost of using the US Census infrastructure even on an annual basis is dwarfed the 
estimated $3.2 trillion spent by the US in health care in 2015.13  In addition, recent advances in science and 
technology are now accelerating the ability to potentially understand larger populations in more detail using 
very cost-efficient tools.  These advances are tempered by forces opposing the growth of population health 
research.   
 
Forces Accelerating Change 
 
Forces accelerating change include, but are not limited to, genomics, electronic health records, and 
data sciences.   
Gregor Mendel’s 1865 presentation on the laws governing the transmission of heritable traits in peas is 
commonly viewed as the foundation of genetics as a scientific discipline.14 However, it took almost a century to 
determine that DNA was the biologic structure governing inheritance.15  Further foundational work led to the 
willingness to initiate the Human Genome Project in 1990 to characterize the DNA in human chromosomes, 
including all genes.  It took until 2003 for the human genome sequence to be completed.16  In 2003, the cost 
associated with generating the first complete human genome sequence was estimated to be between $500 
million and $1 billion dollars.17  With advances in technique in the last decade, the cost of sequencing the 23 
chromosomes and 3 billion base-pairs of the human genome has dropped to about $1000 dollars.18  Currently, 
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every person is able to submit a DNA sample to a commercial entity and for about $200 obtain their ancestry 
and basic health information.19 
In 2010, efforts significantly increased to digitize health care records.  In 2008, there were no states 
where the percent of non-federal acute care hospitals that had adopted at least a Basic Electronic Health 
Record was over 60%.20  By 2014, all States had more than 60% of their non-federal acute care hospitals with 
adoption of a basic electronic health record.21 
The explosion of health data from multiple electronic sources along with sophisticated data science 
tools to organize and analyze the data has led to the development of highly dimensional information.  Within a 
single person, we are able to understand various levels of information from the clinical data from medical 
histories, the genome, the transcriptome, the proteome, the metabolome, and the microbiome.22  While the 
genome represents an organism’s complete set of DNA including all of its genes, the transcriptome is the set 
of all messenger RNA (the molecules that translate genes into proteins) in a single cell or population of cells 
and the proteome is the entire set of proteins expressed by a genome in a given type of cell at a given time 
under defined conditions.  In addition to the detailed understanding of the pathways connecting DNA to 
proteins, the metabolome refers to the complete set of small-molecule chemicals found within a biological 
sample and the microbiome is the curation of microorganisms and their collective genetic material present in or 
on the human body.  Given that advanced tools and technology related to “-omics” are not able to process a 
large number of samples in semi-automated or automated ways at a reduced expense, this level of detail on 
large numbers of individuals can be collected effectively.  Using data science and computing technologies, we 
can analyze the network of relationships between these multiple layers along with relationships with community 
level and environmental data sets.   
These advances, in addition to mobile technologies and patient partnerships, have led to the National 
Institutes of Health proposing the Precision Medicine Initiative to better appreciate how the connected, multi-
level information can be utilized.23  Precision medicine is an emerging approach for prevention and treatment 
of disease that takes into account people’s individual variations in genes, environment, and lifestyle.24  The 
scientific evidence to move the precision medicine concept into clinical practice is underway.  The All of Us 
Research Program is one component of the Precision Medicine Initiative.25  It involves engaging over 1 million 
volunteers residing in the United States who will share genetic data, biological samples, and diet/lifestyle 
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information that can be linked with their electronic health records, if they choose.26  In this new model of doing 
science through engaged participants, responsible data sharing, and privacy protection, the generalizable 
knowledge from the cohort will (1) advance pharmacogenomics (the right drug for the right patient at the right 
dose), (2) identify new targets for treatment and prevention, (3) test whether mobile devices can encourage 
healthy behaviors, and (4) lay a scientific foundation for precision medicine for many diseases, common and 
rare.27  The National Evidence Generation Infrastructure by the United States FDA also is being proposed to 
link data from multiple sources with the National Institutes of Health (“NIH”), the Patient-Centered Outcomes 
Research Institute (“PCORI”), the Centers for Disease Control and Prevention (“CDC”), and industry to impact 
medical product safety surveillance.28 
 
Forces Resisting Change 
 
In the movement towards greater health data utilization for research, forces resisting change include 
various laws created at times when technological advances did not exist.  Before the Health Insurance 
Portability and Accountability Act (“HIPAA”) was signed into law in 1996, there was not a patient privacy 
standard at the federal level for Protected Health Information.29  HIPAA simplified the administrative processes 
for health data transfer for health care treatment, operations, and payments and provided administrative, 
physical and technical safeguards for Protected Health Information.30  Through the passage of the American 
Recovery and Reinvestment Act – Health Information Technology for Economic and Clinical Health 
(“HITECH”), the HIPAA Privacy Rule was extended to include new civil penalties for violations, to have covered 
entities and business associated comply, and to establish breach notification obligations in an Act mainly 
designed to provide specific incentives to accelerate the adoption of electronic health record systems among 
providers.31  With the introduction of Meaningful Use guidelines for Electronic Health Records in 2010 by the 
Centers for Medicare and Medicaid Services (“CMS”), the conducting of a security risk analysis was added in 
the list of compliance measures for which health systems could obtain incentives.32   
While the laws and regulations helped with clinical care processes, they made the connection of data 
from clinical care to research more difficult. A report from the Institute of Medicine Committee in 2009 
concluded that the HIPAA Privacy Rule does not protect privacy as well as it should and impedes important 
health research.33  Also, the lack of an overall coordination between federal level privacy laws and regulations 
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along with varying state laws and regulations creates a complex and sometimes contradictory set of rules to 
follow when conducting population health studies in many states.   
 
III. TENSIONS 
 
The factors accelerating population health research and those resisting change create a tension that 
requires resolution.34 Each person has a “data privacy meter” that goes from not minding who has access to 
their personal health data to wanting tight control over their data at all times.  Where someone sits on the 
meter can vary by social climate, personal risk tolerance, and by the type of data being shared.  While there is 
significant support for open data for solving health issues, there is a countering force of ensuring a high level of 
privacy controls.  This leads to the untenable situation where perfect privacy is only obtained when no data is 
shared or where open access for health research for societal benefit leads to complete loss of personal 
privacy.  The ideal solution set will require innovation that lowers the risk or perceived risk for individuals while 
enabling the efficiency and quality of population health research.   
The issue raised in population health research is a subset of the broader tension between the benefits 
and protections for the individual and the benefits and protections for society where each group is interlinked.   
Individuals influence a society and society influences individuals. A mutually satisfactory balance for individuals 
and society is an iterative process that is usually achieved by policy and technology solutions.  Some of the 
solutions may be found within the domain of population health research and some of the solutions may come 
from other domains with similar individual-society tensions.  Most likely, the solution framework will need to 
address key principles of inclusive governance and power sharing among key stakeholders and transparency 
regarding the process of decision making and the information and processes used to make decisions.  
Philosophies of social justice and human rights will need to be considered.  
 
IV. POTENTIAL SOLUTIONS 
 
Evolutionary Steps 
 
Evolutionary steps involve making subtle, iterative advances from existing frameworks to finding the right 
balance between data sharing and data privacy.  Inter-institutional trust models among entities holding and 
generating data and enabling that data to go through an intermediary to an end-user for research can be 
managed through contractual agreements.  These include business associate agreements, data services 
agreements, data use agreements for limited data sets, and consent for sharing protected health information.  
However, the need to execute one off agreements for each scenario can be cumbersome.  Others have begun 
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creating data repositories with IRB approval and participant consent to hold data for current and future 
research opportunities as an alternative approach. 
 
 
 
 
Disruptive Innovation Steps 
 
Disruptive Innovation is a theory that has taken systems that are large, complicated and expensive, and 
through various processes, simplified, increased efficiencies and cost effectiveness of this theory.35  Some 
potential “disruptive innovations” to improve healthcare are listed below: 
 
Options Other than Written Informed Consent Process.  More disruptive solutions have included an “opt out” 
vs. “opt in” research framework where persons who do not acknowledge that they do not want their health data 
shared will be volunteering to have their data shared.36  Broad notification rather individual notification could be 
used along with community consultation.37  
 
Use of Privacy Standards Other than HIPAA.  Another option is to use a privacy standard other than HIPAA.  
For instance, a framework that obligates persons and entities who collect, access and disclose information to 
adopt responsible data stewardship practices, regardless of whether or not data subjects have provided 
consent and where privacy rests primarily on the data holders has been used in the telecommunications 
industry.38  The Fair Information Practice Principles (“FIPPS”) includes providing a framework of policies 
regarding openness and transparency; purpose specification; collection limitation and data minimization; use 
limitations; individual participation and control; data quality and integrity; security safeguards and controls; 
accountability and oversight; and remedies.39 
 
Compensation Programs.  Another option is to reduce the risk of harm for all involved through insurance 
mechanisms.  For instance, after lawsuits against vaccine companies and health care providers threatened to 
reduce vaccine supply and vaccination rates, the National Vaccine Injury Compensation Program was created 
in the 1980s.40  It had a framework that rare but anticipated serious adverse events could occur with vaccines.  
It established a no-fault alternative to the traditional legal system for resolving vaccine injury petitions.41  A 
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similar federal insurance structure could be created with health systems engaged in research with protected 
health information where even with the best controls breaches can occur.  The health systems can pay into 
such a system and compensate individuals with the purchase of identity monitoring over time.  
 An alternative to paying claims after an event has occurred could be for health systems to offer identity 
protection insurance for any person seeking care institutions and enabling persons to access identity 
preservation services if a breach occurs through these commercial entities.   
 
V. CONCLUSION 
 
In 1979, The Belmont Report laid out the Ethical Principles for Human Research.42  These included 
respect for persons, beneficence and justice.43  This framework still holds as we think about the acceleration of 
population health research to create a social good for all.  Respect for persons includes understanding their 
personal privacy setting and to come to some shared decisions about when to share and not share 
information.  Beneficence focuses of minimizing risk of harm in situations where all the outcomes are not 
known.  Justice involves not having a single group take the risk for all that would benefit.  In the end, there is 
significant promise in improving the value of health and in reducing suffering with the advanced technologies 
that generate information about the mechanisms leading to health.  We still have to find the right way to 
advance the “commons” of population health research in order to provide health equity while maintaining the 
highest level of respect and responsibility for persons who volunteer to be part of population health research. 
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